The panel shares their credentials and breadth of expertise
The future of canine parvovirus treatment
Our panel weighs in on the heavy toll of this devastating disease
Panelists discuss how Parvo management changed during the COVID-19 pandemic
How Parvo affects the human/animal bond
Panelists discuss how to boost hospital morale while managing Parvo cases
The panel explains how Parvo affects early development for puppies and shares advice for pet parents
Panelists share their excitement regarding the new canine Parvovirus monoclonal antibody
How CPMA works and how it differs from pre-existing treatment options
Contraindications and things to look out for while using CPMA for treatment
Panelists share their experiences with using CPMA for Parvo treatment
The panel discusses how CPMA impacts survivability, hospital morale, and the human/animal bond
How cost, accessibility, and patient condition affect treatment
How monoclonal antibodies like CPMA can help change the future of veterinary medicine
Advertisement
Advertisement
Trending on dvm360
1
FDA issues emergency use authorization for ivermectin solution to prevent screwworm in horses
2
Every 30 extra minutes under anesthesia raises complication risk in brachycephalic patients, underscoring the importance of peri-anesthetic management
3
From the CVO: I’m off the clock
4
Paws and profits: VetEvolve names first chief veterinary officer, NVA appoints two board members, and more updates
5